You searched for "PET-CT"

129 results found

Coros: can a smart helmet make listening to audio content safer for cyclists?

The popularity of mobile phones has made listening to content while on the go – whether it be music, audiobooks, podcasts, or voice calls – a seemingly universal practice. Earbuds and other headphone styles adorn the ears of nearly every...

BIOHIT HealthCare and the British Laryngological Association agree to corporate partnership

BIOHIT HealthCare is pleased to announce its corporate partnership with the British Laryngological Association (BLA) for 2022-2023, which brings together two organisations with the mission to advance laryngology diagnostics.

BIOHIT HealthCare is exhibiting at the BSI congress 2022

BIOHIT HealthCare is excited to be exhibiting at this year’s British Society for Immunology (BSI) Congress in Liverpool.

BIOHIT launches new quick test to help streamline gastroscopy referrals

BIOHIT HealthCare Ltd will be attending the upcoming BSG Live 2023 conference in Liverpool, where it will unveil a revolutionary new test to support decision making for gastroscopy referrals and improve the early detection of gastric cancer.

Patient initiated follow-up in head and neck cancer

Is it time for a change in the way we follow up head and neck cancer patients after treatment? Paul Nankivell and Hisham Mehanna explain the rationale for the PETNECK2 trial. After completion of curative intent treatment, clinical follow-up currently...

Otoacoustic emissions in the diagnostic test battery for hearing loss

So, they are great for screening, but how can otoacoustic emissions be integrated into the diagnostic test battery? Beth Prieve examines the role of diagnostic OAEs by asking three simple questions. Audiologists and otolaryngologists are familiar with otoacoustic emissions (OAEs)...

The changing landscape for hearing loss therapeutics: novel advances of gene and cell therapies

Recent years have seen advances in hearing loss therapeutics, with novel treatments trialled in humans, and others nearing promising first-in-kind clinical trials. First successful clinical trials for a specific form of genetic hearing loss Very exciting news has emerged in...

Making audiology work during COVID-19 and beyond

‘New normal’ is another phrase that has become synonymous with this pandemic. In this article, consideration for ‘low-touch’ and ‘no touch’ audiological pathways are described for adoption as the ‘new normal’ for hearing healthcare. The COVID-19 crisis has ushered in...

Thyroid nodules – time for a rational imaging approach

“The more you know, the harder it is to take decisive action. Once you become informed, you start seeing complexities and shades of gray. You realize that nothing is as clear as it first appears. Ultimately, knowledge is paralyzing.” Calvin,...

Imaging tinnitus

Tinnitus is a common sensation with a reported prevalence of 7-32%. The British National Study of Hearing recorded that 10% of adults suffered from prolong spontaneous tinnitus, and approximately a quarter of these are subsequently referred to hospital for investigation...

The challenges in the risk stratification of thyroid nodules and cancers: the role of molecular testing

Around the world, molecular testing is becoming more widely used to personalise the management of thyroid nodules. Thyroid nodules are relatively common. They are palpable in ~5% of the population, while high-resolution ultrasound (US) incidentally finds them in 19–68% of...

Illuminating ear education: building interactive models to enhance inner ear understanding

Understanding the anatomy and function of the inner ear, particularly the vestibular apparatus and cochlea, is fundamental to audiology and otolaryngology education. However, the complex geometry and intricate functional relationships of these structures challenge us to find clear ways to...